biogen’s-potentially-game-changing-alzheimer’s-drug-still-faces-an-uphill-battle-with-the-fda

“It’s a complete coin flip that will now be in the hands of the FDA,” says Jared Holz, a health-care strategist at Jefferies.

Disclaimer : India Connecting is a news, information, article aggregation portal, as an aggregator contents are sourced from different providers as highlighted with every news, information,article. India Connecting is not accountable or responsible for any aggregated, sourced content. We can be reached at contact@indiaconnecting.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here